EquityZen Growth Technology Fund LLC - Series 137
Raised
$1M
Investors
39
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 137 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors on 2017-09-05, raising $1.3M from 39 investors under Rule 506(b) and Section 3(c)(1). The offering features a $10K minimum investment and is part of EquityZen's platform of pre-IPO secondary market access vehicles, with over 1,800 related entities on record.
This pre-IPO pooled fund employs the standard 506(b)/3(c)(1) exemption structure common to private investment vehicles, with a retail-accessible $10K minimum positioning it toward the lower end of the market. The $33K average check size (39 investors into $1.3M) reflects a crowdfunded participation model typical of secondary marketplace platforms enabling fractional exposure to private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Erin Rosenthal
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shiraram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
